This brand name is authorized in Australia, Canada, United States
The drug EDECRIN contains one active pharmaceutical ingredient (API):
1
Etacrynic acid
UNII M5DP350VZV - ETHACRYNIC ACID
|
Ethacrynic acid is a monosulfonamyl loop or high ceiling diuretic. Ethacrynic acid acts on the ascending limb of the loop of Henle and on the proximal and distal tubules. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
EDECRIN Tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
C03CC01 | Etacrynic acid | C Cardiovascular system → C03 Diuretics → C03C High-ceiling diuretics → C03CC Aryloxyacetic acid derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 8748K |
Country: CA | Health Products and Food Branch | Identifier(s): 02258528 |
Country: US | FDA, National Drug Code | Identifier(s): 25010-215 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.